dimyristoylphosphatidylcholine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Guo, W; Li, C; Li, Y; Liang, M; Wang, C; Wang, L; Yang, H; Zhang, L | 1 |
| Ichihara, H; Kanno, A; Matsumoto, Y; Tsuzaki, K; Ueoka, R | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Experimental Neoplasms
| Article | Year |
|---|---|
Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Cholesterol; Dimyristoylphosphatidylcholine; Drug Compounding; Half-Life; Hydrogen-Ion Concentration; Injections, Intravenous; Liposomes; Male; Mice; Mitoxantrone; Neoplasms, Experimental; Nickel; Phosphatidylcholines; Solubility | 2009 |
Marked therapeutic effect of dimyristoylphosphatidylcholine liposomes on carcinoma mice model in vivo.
Topics: Animals; Antineoplastic Agents; Dimyristoylphosphatidylcholine; Erythrocyte Count; Humans; Leukocyte Count; Liposomes; Melanoma, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Phospholipids; Rats; Survival Analysis | 2000 |